Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 9—September 2010

Dispatch

Increasing Incidence of Mucormycosis in University Hospital, Belgium

Veroniek Saegeman, Johan Maertens, Wouter Meersseman, Isabel Spriet, Eric Verbeken, and Katrien LagrouComments to Author 
Author affiliations: Author affiliation: Leuven University Hospitals, Leuven, Belgium

Main Article

Table

Specific annual incidence rate of mucormycosis cases per risk group in a hospital in Belgium, 2000–2008*

Year Diabetes mellitus Solid organ transplantation Hematologic disorder/ malignancy HSCT
2000 0/3,087 0/235 1/684 0/96
2001 0/3,328 0/217 2/557 1/86
2002 0/3,319 0/207 0/650 0/87
2003 0/3,662 0/245 0/775 0/118
2004 1/3,845 0/217 0/787 0/126
2005 1/4,121 1/191 1/853 0/103
2006 0/4,235 2/251 5/1,061 3/91
2007 0/4,328 0/279 0/942 0/121
2008
0/4,477
1/267
3/859
1/116
p value for the increase in
No. patients per risk group <0.01 0.12 <0.01 0.19
Specific annual incidence rate 0.81 0.11 0.91 0.55

*Values are no. cases per risk group/no. patients admitted per year with that risk factor, unless otherwise indicated. Data for risk group patients based on codes from the International Classification of Diseases, 9th Revision, Clinical Modification, available 2000–2008. HSCT, hematopoietic stem cell transplantation.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO